SS

Sushama Singh

Active Director Director DIN 03215114
DIN 03215114 First appointment Apr 2015 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2015
Shareholding value •••• Premium profile

About Sushama Singh

Data last updated:

Sushama Singh is a Director at Gamete Pharma Private Limited (since 2015). The company operates in Trading. Gamete Pharma Private Limited reported revenue of ₹1.86 Cr (FY 2024).

DIN 03215114
Primary Designation Director
Industry Trading
First Appointment 24 Apr 2015
Oldest Company Age 20 yrs
Largest company Gamete Pharma Private Limited · ₹1.86 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gamete Pharma Private Limited U24232UP2006PTC032172
Director24 Apr 20152006₹1.86 Cr (FY 2024)Active

Board colleagues of Sushama Singh

NameDINCompanyDesignation
Jitendra Kumar Singh03214847Gamete Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gamete Pharma Private Limited
Premium access

Shareholding and investment profile for Sushama Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushama Singh

Sushama Singh currently holds 1 directorship: Gamete Pharma Private Limited (Director, since 24 Apr 2015, revenue ₹1.86 Cr (FY 2024)).

Sushama Singh was first appointed on 24 Apr 2015 as Director at Gamete Pharma Private Limited.

The current boards of Sushama Singh's companies include Jitendra Kumar Singh (Gamete Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available